CONMED Q4 international revenue rises 17.0% to USD 163.5 million

Reuters

Jan 29

CONMED Q4 international revenue rises 17.0% to USD 163.5 million

CONMED Corporation (NYSE: CNMD) reported its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. For Q4 2025, sales reached USD 373.2 million, representing a 7.9 percent increase. Domestic revenue rose by 1.4 percent, while international revenue increased by 17 percent. Diluted net earnings per share (GAAP) were USD 0.54, and adjusted diluted net earnings per share were USD 1.43. For the full year 2025, sales totaled USD 1.4 billion, up 5.2 percent. Domestic revenue increased by 3.5 percent, and international revenue grew by 7.4 percent. Diluted net earnings per share (GAAP) for the year were USD 1.51, and adjusted diluted net earnings per share were USD 4.59. Gross profit for Q4 2025 was USD 218.3 million. For the full year, gross profit stood at USD 750.5 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CONMED Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260128818404) on January 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2607406277"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2607406277\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2607406277?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 05:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607406277","market":"fut","top_or_hot":-1,"title":"CONMED Q4 international revenue rises 17.0% to USD 163.5 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      CONMED Q4 international revenue rises 17.0% to USD 163.5 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/CNMD\">CONMED Corporation</a> (NYSE: CNMD) reported its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. For Q4 2025, sales reached USD 373.2 million, representing a 7.9 percent increase. Domestic revenue rose by 1.4 percent, while international revenue increased by 17 percent. Diluted net earnings per share (GAAP) were USD 0.54, and adjusted diluted net earnings per share were USD 1.43. For the full year 2025, sales totaled USD 1.4 billion, up 5.2 percent. Domestic revenue increased by 3.5 percent, and international revenue grew by 7.4 percent. Diluted net earnings per share (GAAP) for the year were USD 1.51, and adjusted diluted net earnings per share were USD 4.59. Gross profit for Q4 2025 was USD 218.3 million. For the full year, gross profit stood at USD 750.5 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CONMED Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260128818404) on January 28, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CONMED Q4 international revenue rises 17.0% to USD 163.5 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCONMED Q4 international revenue rises 17.0% to USD 163.5 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-29 05:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      CONMED Q4 international revenue rises 17.0% to USD 163.5 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/CNMD\">CONMED Corporation</a> (NYSE: CNMD) reported its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. For Q4 2025, sales reached USD 373.2 million, representing a 7.9 percent increase. Domestic revenue rose by 1.4 percent, while international revenue increased by 17 percent. Diluted net earnings per share (GAAP) were USD 0.54, and adjusted diluted net earnings per share were USD 1.43. For the full year 2025, sales totaled USD 1.4 billion, up 5.2 percent. Domestic revenue increased by 3.5 percent, and international revenue grew by 7.4 percent. Diluted net earnings per share (GAAP) for the year were USD 1.51, and adjusted diluted net earnings per share were USD 4.59. Gross profit for Q4 2025 was USD 218.3 million. For the full year, gross profit stood at USD 750.5 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CONMED Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260128818404) on January 28, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0757428866.USD","symbol_name":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDLbwdnY3:1","article_id":"2607406277","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607406277","pubTimestamp":1769634399,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"CONMED Corporation  reported its financial results for the fourth quarter  and full year  ended December 31, 2025. For Q4 2025, sales reached USD 373.2 million, representing a 7.9 percent increase. Domestic revenue rose by 1.4 percent, while international revenue increased by 17 percent. Diluted net earnings per share  were USD 0.54, and adjusted diluted net earnings per share were USD 1.43. For the full year 2025, sales totaled USD 1.4 billion, up 5.2 percent. Domestic revenue increased by 3.5 percent, and international revenue grew by 7.4 percent. Diluted net earnings per share  for the year were USD 1.51, and adjusted diluted net earnings per share were USD 4.59. Gross profit for Q4 2025 was USD 218.3 million. For the full year, gross profit stood at USD 750.5 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","BK4082":"医疗保健设备","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","LU1878469433.USD":"THREADNEEDLE (LUX) - AMERICAN SMALLER COMPANIES \"A\" (USD) ACC","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","CNMD":"CONMED Corporation"},"translate_title":"CONMED第四季度国际收入增长17.0%至1.635亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNMD":0.9},"content_text":"CONMED Q4 international revenue rises 17.0% to USD 163.5 million\n    \n\nCONMED Corporation (NYSE: CNMD) reported its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. For Q4 2025, sales reached USD 373.2 million, representing a 7.9 percent increase. Domestic revenue rose by 1.4 percent, while international revenue increased by 17 percent. Diluted net earnings per share (GAAP) were USD 0.54, and adjusted diluted net earnings per share were USD 1.43. For the full year 2025, sales totaled USD 1.4 billion, up 5.2 percent. Domestic revenue increased by 3.5 percent, and international revenue grew by 7.4 percent. Diluted net earnings per share (GAAP) for the year were USD 1.51, and adjusted diluted net earnings per share were USD 4.59. Gross profit for Q4 2025 was USD 218.3 million. For the full year, gross profit stood at USD 750.5 million.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CONMED Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260128818404) on January 28, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}